PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SLNO vs. RXST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


SLNORXST
YTD Return47.03%14.91%
1Y Return169.00%83.27%
3Y Return (Ann)73.28%56.00%
Sharpe Ratio2.781.76
Sortino Ratio3.272.57
Omega Ratio1.391.31
Calmar Ratio1.732.59
Martin Ratio13.526.53
Ulcer Index12.37%14.50%
Daily Std Dev60.19%53.68%
Max Drawdown-99.86%-48.21%
Current Drawdown-90.98%-27.94%

Fundamentals


SLNORXST
Market Cap$2.55B$1.87B
EPS-$2.79-$0.81
Total Revenue (TTM)$3.45M$138.39M
Gross Profit (TTM)$1.97M$87.81M
EBITDA (TTM)-$133.09M-$34.45M

Correlation

-0.50.00.51.00.2

The correlation between SLNO and RXST is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

SLNO vs. RXST - Performance Comparison

In the year-to-date period, SLNO achieves a 47.03% return, which is significantly higher than RXST's 14.91% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
38.27%
-21.20%
SLNO
RXST

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SLNO vs. RXST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SLNO
Sharpe ratio
The chart of Sharpe ratio for SLNO, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.002.78
Sortino ratio
The chart of Sortino ratio for SLNO, currently valued at 3.27, compared to the broader market-4.00-2.000.002.004.006.003.27
Omega ratio
The chart of Omega ratio for SLNO, currently valued at 1.39, compared to the broader market0.501.001.502.001.39
Calmar ratio
The chart of Calmar ratio for SLNO, currently valued at 5.76, compared to the broader market0.002.004.006.005.76
Martin ratio
The chart of Martin ratio for SLNO, currently valued at 13.52, compared to the broader market0.0010.0020.0030.0013.52
RXST
Sharpe ratio
The chart of Sharpe ratio for RXST, currently valued at 1.76, compared to the broader market-4.00-2.000.002.004.001.76
Sortino ratio
The chart of Sortino ratio for RXST, currently valued at 2.57, compared to the broader market-4.00-2.000.002.004.006.002.57
Omega ratio
The chart of Omega ratio for RXST, currently valued at 1.31, compared to the broader market0.501.001.502.001.31
Calmar ratio
The chart of Calmar ratio for RXST, currently valued at 2.59, compared to the broader market0.002.004.006.002.59
Martin ratio
The chart of Martin ratio for RXST, currently valued at 6.53, compared to the broader market0.0010.0020.0030.006.53

SLNO vs. RXST - Sharpe Ratio Comparison

The current SLNO Sharpe Ratio is 2.78, which is higher than the RXST Sharpe Ratio of 1.76. The chart below compares the historical Sharpe Ratios of SLNO and RXST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
2.78
1.76
SLNO
RXST

Dividends

SLNO vs. RXST - Dividend Comparison

Neither SLNO nor RXST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SLNO vs. RXST - Drawdown Comparison

The maximum SLNO drawdown since its inception was -99.86%, which is greater than RXST's maximum drawdown of -48.21%. Use the drawdown chart below to compare losses from any high point for SLNO and RXST. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember0
-27.94%
SLNO
RXST

Volatility

SLNO vs. RXST - Volatility Comparison

The current volatility for Soleno Therapeutics, Inc. (SLNO) is 6.85%, while RxSight, Inc. (RXST) has a volatility of 13.66%. This indicates that SLNO experiences smaller price fluctuations and is considered to be less risky than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
6.85%
13.66%
SLNO
RXST

Financials

SLNO vs. RXST - Financials Comparison

This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items